D.-Q. Xu et al.
SHORT COMMUNICATION
but also constrains it to a well-defined orientation, which is
furthermore enhanced by the two chiral substituted ends of
the squaramide. The deprotonated form of 2-hydroxy-1,4-
Acknowledgments
This work was supported by the National Natural Science Founda-
naphthoquinone (1) is assumed to interact with the tertiary tion of China (No. 20772110).
amine group of the catalyst through the hydrogen bonds
between the protonated amine and the two vicinal oxygen
[1] a) A. Berkessel, H. Gröger, Asymmetric Organocatalysis, Wiley-
atoms of 1, which is also activated and fixed by a bidentate
interaction. The well-induced transition state facilitates the
nucleophile 1 to attack the oxo ester 2a from the re face
and to form the (R) product.
VCH, Weinheim 2005; b) P. I. Dalko, Enantioselective Organo-
catalysis, Wiley-VCH, Weinheim, 2007.
[2] For recent selected reviews of hydrogen-bonding activation,
see: a) Z. G. Zhang, P. R. Schreiner, Chem. Soc. Rev. 2009, 38,
1187–1198; b) S. J. Connon, Chem. Commun. 2008, 2499–2510;
c) X. H. Yu, W. Wang, Chem. Asian J. 2008, 3, 516–532; d)
A. G. Doyle, E. N. Jacobsen, Chem. Rev. 2007, 107, 5713–5743;
e) S. J. Connon, Chem. Eur. J. 2006, 12, 5418–5427; f) M. S.
Taylor, E. N. Jacobsen, Angew. Chem. 2006, 118, 1550; Angew.
Chem. Int. Ed. 2006, 45, 1520–1543; g) T. Akiyama, J. Itoh, K.
Fuchibe, Adv. Synth. Catal. 2006, 348, 999–1010.
[3] For recent selected examples of this bifunctional system, see:
a) B. Tan, Y. Lu, X. Zeng, P. J. Chua, G. Zhong, Org. Lett.
2010, 12, 2682–2685; b) X. Han, J. Kwiatkowski, F. Xue, K. W.
Huang, Y. X. Lu, Angew. Chem. 2009, 121, 7740–7741; Angew.
Chem. Int. Ed. 2009, 48, 7604–7607; c) G. Dickmeiss, V. De Sio,
J. Udmark, T. B. Poulsen, V. Marcos, K. A. Jørgensen, Angew.
Chem. 2009, 121, 6778–6781; Angew. Chem. Int. Ed. 2009, 48,
6650–6653; d) W. J. Nodes, D. R. Nutt, A. M. Chippindale,
A. J. A. Cobb, J. Am. Chem. Soc. 2009, 131, 16016–16017; e)
T. Bui, S. Syed, C. F. Barbas, J. Am. Chem. Soc. 2009, 131,
8758; f) D. R. Li, A. Murugan, J. R. Falck, J. Am. Chem. Soc.
2008, 130, 46–48; g) J. Wang, H. X. Xie, H. Li, L. S. Zu, W.
Wang, Angew. Chem. 2008, 120, 4245–4247; Angew. Chem. Int.
Ed. 2008, 47, 4177–4179; h) C. Gioia, A. Hauville, L. Bernardi,
F. Fini, A. Ricci, Angew. Chem. 2008, 120, 9376–9379; Angew.
Chem. Int. Ed. 2008, 47, 9236–9239; i) Y. Q. Fang, E. N. Ja-
cobsen, J. Am. Chem. Soc. 2008, 130, 5660–5661; j) C. J. Wang,
X. Q. Dong, Z. H. Zhang, Z. Y. Xue, H. L. Teng, J. Am. Chem.
Soc. 2008, 130, 8606–8607; k) C. Rabalakos, W. D. Wulff, J.
Am. Chem. Soc. 2008, 130, 13524–13525.
[4] a) V. K. Tandon, D. B. Yadav, R. V. Singh, A. K. Chaturvedi,
P. K. Shukla, Bioorg. Med. Chem. Lett. 2005, 15, 5324–5328;
b) I. Gomez-Monterrey, G. Santelli, P. Campiglia, D. Califano,
F. Falasconi, C. Pisano, L. Vesci, T. Lama, P. Grieco, E. Nov-
ellino, J. Med. Chem. 2005, 48, 1152–1157; c) M. Glänzel, R.
Bültmann, K. Starke, A. W. Frahm, Eur. J. Med. Chem. 2005,
40, 1262–1276; d) V. K. Tandon, R. B. Chhor, R. V. Singh, S. J.
Rai, D. B. Yadav, Bioorg. Med. Chem. Lett. 2004, 14, 1079–
1083; e) A. G. Ravelo, A. Estevez-Braun, H. Chavez-Orellana,
E. Perez-Sacau, D. Mesa-Siverio, Curr. Top. Med. Chem. 2004,
4, 241–265; f) V. F. de Andrade-Neto, M. O. F. Goulart, J. F.
da Silva, M. J. da Silva, M. D. Pinto, A. V. Pinto, M. G. Zalis,
L. H. Carvalho, A. U. Krettli, Bioorg. Med. Chem. Lett. 2004,
14, 1145–1149; g) M. Glänzel, R. Bültmann, K. Starke, A. W.
Frahm, Eur. J. Med. Chem. 2003, 38, 303–312.
[5] a) M. Rueping, E. Sugiono, E. Merino, Angew. Chem. 2008,
120, 3089–3092; Angew. Chem. Int. Ed. 2008, 47, 3046–3049;
b) W. M. Zhou, H. Liu, D. M. Du, Org. Lett. 2008, 10, 2817–
2820.
[6] For the chiral copper(II) complex catalyzed one, see: N. Hal-
land, T. Velgaard, K. A. Jørgensen, J. Org. Chem. 2003, 68,
5067–5074.
[7] For recent selected examples of using β,γ-unsaturated α-oxo
esters as substrates, see: a) S. L. Zhao, C. W. Zheng, H. F.
Wang, G. Zhao, Adv. Synth. Catal. 2009, 351, 2811–2816; b)
C. W. Zheng, Y. W. Li, Y. Q. Yang, H. F. Wang, H. F. Cui, J. K.
Zhang, G. Zhao, Adv. Synth. Catal. 2009, 351, 1685–1691; c)
M. A. Calter, J. Wang, Org. Lett. 2009, 11, 2205–2208; d) S. L.
Zhao, C. W. Zheng, G. Zhao, Tetrahedron: Asymmetry 2009,
20, 1046–1051; e) H. F. Wang, C. W. Zheng, Y. Q. Yang, Z.
Chai, G. Zhao, Tetrahedron: Asymmetry 2008, 19, 2608–2615;
f) X. S. Wang, C. W. Zheng, S. L. Zhao, Z. Chai, G. Zhao, G. S.
Figure 3. Proposed transition state of the organocatalytic enantio-
selective Michael reaction.
Conclusions
We have developed a novel highly enantioselective organo-
catalytic Michael addition of 2-hydroxy-1,4-naphthoquin-
one to β,γ-unsaturated α-oxo esters catalyzed by readily
available cinchona-derived squaramides with low catalyst
loading (2.5–5 mol-%) to provide an expeditious access to-
ward highly functionalized naphthoquinone derivatives in
good yields (73–88%) and with excellent enantioselectivities
(87–98% ee). Considering the high efficiency of the potent
transformations, further investigation on the application of
chiral squaramides in organocatalysis is in progress in our
laboratory.
Experimental Section
Typical Procedure for the Organocatalytic Asymmetric Michael Re-
action: To a solution of catalyst IVc (0.0625 mmol, 5 mol-%) in
dioxane (1.0 mL), 2-hydroxy-1,4-naphthoquinone (1) (0.125 mmol)
and β,γ-unsaturated α-oxo ester 2a (0.125 mmol) were added se-
quentially. The reaction mixture was then stirred at room tempera-
ture (about 25 °C) for 12 h. The crude mixture was purified by flash
chromatography to furnish a yellow solid in 83% yield. The process
was clear and no 1,2-addition or oxa-Michael addition product
formed. The enantiomeric excess was determined by HPLC with a
Chiralpak AD-H column [hexane/iPrOH = 70:30 containing 0.15%
TFA; flow rate 1.0 mL/min; tR(major isomer) = 9.9 min, tR(minor
isomer) = 13.6 min].
Supporting Information (see footnote on the first page of this arti-
cle): 1H and 13C NMR spectra, mass spectra, HPLC analysis data.
4984
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 4981–4985